Electrochemotherapy in Spine Metastases: A Case Series Focused on Technical Aspects, Surgical Strategies and Results.
Andrea AngeliniAlberto D'AmicoStefania PaolilliRiccardo SignoriGiovanni BaldinGiuseppe Di RubboLuca DenaroPietro RuggieriPublished in: Diagnostics (Basel, Switzerland) (2024)
Metastases are complications of primary tumors due to prolonged cancer survival and have become an important issue for oncological patients and the most frequent cause of death and disability. Bone metastases occur at a later stage of cancer disease, and the spine is the most frequent site. To date, the aim of the treatment of metastases remains to be the control of disease and provide a satisfactory quality of life. The decision making of treatment is influenced by several factors such as the status of the primary disease, the number of metastases, site involvement, and the performance status of the patients. For this reason, the treatment of metastases is challenging and undergoes constant development. Therefore, alternative techniques with respect to surgery, which is the first option but not always practicable, and radiochemotherapy are attractive. Lately, electrochemotherapy has emerged as an innovative method for treating various primary and metastatic solid tumors, showing promising outcomes in terms of inducing tumor tissue necrosis and alleviating symptoms. This technique uses electric pulses to increase the uptake of chemotherapy by tumor cells. Despite the initial enthusiasm and good results in the treatment of bone tumors, relatively few papers have described its use in spine metastases. Therefore, we conducted a systemic review of this intriguing topic while also reporting our experience in the use of electrochemotherapy for the treatment of spine metastases.
Keyphrases
- end stage renal disease
- chronic kidney disease
- small cell lung cancer
- newly diagnosed
- squamous cell carcinoma
- multiple sclerosis
- emergency department
- prostate cancer
- minimally invasive
- type diabetes
- peritoneal dialysis
- risk factors
- prognostic factors
- combination therapy
- depressive symptoms
- insulin resistance
- body composition
- young adults
- adipose tissue
- atrial fibrillation
- squamous cell
- free survival